FDA Inspection 1283176 — Duke University Health System IRB

Duke University Health System IRB — FEI 1045114

The FDA completed an inspection of Duke University Health System IRB on September 11, 2025 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 11, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Durham, NC (United States)

Additional Details

IRB